Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44

Benzinga · 1d ago
Wedbush analyst Laura Chico initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Outperform rating and announces Price Target of $44.